Karl Palm - Hufvudstaden Head Devel
| HUFAF Stock | USD 12.20 0.00 0.00% |
Insider
Karl Palm is Head Devel of Hufvudstaden AB
| Age | 39 |
| Phone | 46 87 62 90 00 |
| Web | https://hufvudstaden.se |
Hufvudstaden Management Efficiency
The company has return on total asset (ROA) of 0.0159 % which means that it generated a profit of $0.0159 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0898 %, meaning that it generated $0.0898 on every $100 dollars invested by stockholders. Hufvudstaden's management efficiency ratios could be used to measure how well Hufvudstaden manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| CPA MST | Ardelyx | 50 | |
| Dan Pavicich | Ardelyx | N/A | |
| Kimia Keshtbod | Ardelyx | N/A | |
| Laetitia BachelotFontaine | Valneva SE ADR | N/A | |
| Elaine JD | Summit Therapeutics PLC | 63 | |
| Robert Blanks | Ardelyx | 65 | |
| J Stice | MPLX LP | 61 | |
| Michelle Avery | Summit Therapeutics PLC | N/A | |
| Kristina Kazarian | MPLX LP | 42 | |
| Kelly Wright | MPLX LP | 42 | |
| Captain Conway | Ryanair Holdings PLC | 70 | |
| Dara Brady | Ryanair Holdings PLC | N/A | |
| Peter Larkin | Ryanair Holdings PLC | N/A | |
| Rick Hessling | MPLX LP | 57 | |
| Anne Heatherington | Summit Therapeutics PLC | N/A | |
| Suzanne Gagle | MPLX LP | 58 | |
| Ankur Dhingra | Summit Therapeutics PLC | 47 | |
| FRS DBE | Summit Therapeutics PLC | 74 | |
| Divya Chari | Summit Therapeutics PLC | 57 | |
| Karen Harrigan | Ardelyx | N/A | |
| David Whikehart | MPLX LP | 60 | |
Management Performance
| Return On Equity | 0.0898 | |||
| Return On Asset | 0.0159 |
Hufvudstaden AB Leadership Team
Elected by the shareholders, the Hufvudstaden's board of directors comprises two types of representatives: Hufvudstaden inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hufvudstaden. The board's role is to monitor Hufvudstaden's management team and ensure that shareholders' interests are well served. Hufvudstaden's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hufvudstaden's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Fredrik Ottosson, Head of the Gothenburg Business Area | ||
| Bo Wikare, Head of the Stockholm City East Business Area | ||
| Anders Nygren, Head of Property Development | ||
| Asa Roslund, Acting CFO | ||
| Frida Wijkstrom, Head Area | ||
| Karl Palm, Head Devel | ||
| Ulrika Frisk, Head HR | ||
| John Lethenstrom, Head of Property Development | ||
| Mattias Karlsson, Secretary |
Hufvudstaden Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Hufvudstaden a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0898 | |||
| Return On Asset | 0.0159 | |||
| Profit Margin | 1.00 % | |||
| Current Valuation | 3.57 B | |||
| Shares Outstanding | 194.04 M | |||
| Shares Owned By Insiders | 43.77 % | |||
| Shares Owned By Institutions | 29.08 % | |||
| Price To Earning | 7.69 X | |||
| Price To Book | 0.89 X | |||
| Price To Sales | 9.87 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Hufvudstaden Pink Sheet
Hufvudstaden financial ratios help investors to determine whether Hufvudstaden Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hufvudstaden with respect to the benefits of owning Hufvudstaden security.